Saturday 11 February 2012

China Chemical Pharmaceutical Industry Report, 2011

Reportstack, provider of premium market research reports announces the addition of China Chemical Pharmaceutical Industry Report, 2011 market report to its offering

"In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last year, presenting remarkable upward momentum. The chemical pharmaceutical industry of China chiefly comprises two sub-sectors chemical API and drug preparation which show differentiated development.

China is currently the world’s largest producer and exporter of chemical API and can produce more than 1,500 varieties with the capacity approximating 2 or 3 million tons. However, key bulk API products including vitamins and antibiotics witness overcapacity, which has resulted in low-price competition bringing adverse impact on the export of API. In Q1 2011, the API export of China increased by 39.53% year-on-year, with the export value rising 31.31% from the same period of last year, while the average export price fell 5.89% year-on-year. In particular, the average export price of Vitamin C slumped by 30%.

In comparison with chemical API sector, the chemical drug preparation sector of China enjoys higher profitability as a whole, with the gross margin in 2010 hitting 39.6% and two-fold of that of API industry. Yet, chemical preparation industry of China is still in its infancy with short R&D capability of new drugs, and therefore the production of generics is the mainstream.

The report focuses on the market size and development trend of China chemical pharmaceutical industry as well as the market scale of API and chemical preparation on the basis of the outlook for new drug R&D and market development worldwide. In addition, the market planning and new drug R&D of the leading 20 listed industrial players is also analyzed here.


Northeast Pharmaceutical Group Co., Ltd. is one of the largest Vitamin C producers in China. In 2011, the Vitamin C capacity of the company reached 25,000 tons. Currently, its investment is mainly earmarked for API. Also in 2011, it raised funds RMB2.645 billion to build Xihe-based API production base covering Vitamin C API, fosfomycin series products, L-carnitine series, and so forth.

As one of key chemical pharmaceutical companies in China, the operating revenue of. Huadong Medicine Co., Ltd in Jan.-Sep., 2011 increased by 25.51% year-on-year to RMB8.195 billion. Its holding subsidiary, Hangzhou Zhongmei Huadong Pharmaceutical, is regarded as the largest immunosuppressant producer in China.

Jiangsu Hengrui Medicine Co., Ltd is the one with the most new drugs independently developed among pharmaceutical companies in China. In 2011, it filed for the production of four new drugs with ClassⅠ-Ⅲ and for the clinical trial of four new chemical medicines with class Ⅲ-Ⅴ and one biological medicine with class Ⅸ. Moreover, eleven new chemical medicines with class Ⅰ-Ⅴ and one biological medicine with class Ⅸ were under clinical trial. In December 2011, Irinotecan injection developed by Jiangsu Hengrui Medicine Co. won the FDA certification and became qualified to be sold in the US market, which made it be the first of this kind among Chinese peers.

Contact us:
Reportstack http://www.reportstack.com/contact
twitter: http://twitter.com/reportstack
facebook: http://www.facebook.com/pages/Reportstack/182382778485635
linkedin: http://www.linkedin.com/company/reportstack

Global and China Plastic Packaging Industry Report, 2010-2012

Reportstack, provider of premium market research reports announces the addition of Global and China Plastic Packaging Industry Report, 2010-2012 market report to its offering

In the global plastic packaging industry, the CAGR was roughly 7.2% between 2001 and 2010, featuring the fastest growth in packaging industry breakdown. For China, the market scale of plastic packaging industry approximated USD66.4 billion in 2011, accounting for 31.2% of the total worldwide. Currently, the growth in the output of plastic packaging is in proportion to the growth of demand, with the overall industry presenting a balanced supply-demand situation.

Operating Features of China Plastic Packaging Industry

Low Industrial Concentration: the top five businesses in plastic flexible packaging industry accounted for 19.4% market share in 2010. In particular, Huangshan Novel Co., Ltd. was the champion, with the market share making up 7.2%. And the top five businesses in cosmetic plastic packaging industry stood at 26% market share. In particular, Shenzhen Beautystar Company Limited occupied a lion’s share of 8.6%.

Pharmaceutical Packaging Expecting to Become New Contributor for the Growth of Plastic Packaging Industry: in terms of downstream sectors, plastic packaging witnesses the widest application in consumer goods industries like foods & drinks, daily chemical articles and pharmaceutical industries. In 2010, the application of plastic packaging in downstream foodstuff industry, daily chemical articles, pharmaceutical industry and others made up around 70%, 13%, 9%, and 8%, respectively. In developed countries, pharmaceutical packaging occupies 30% of the value of the medicines, while the figure in China is less than 10%. Hence, China pharmaceutical packaging industry is expected to see skyrocketing development in upcoming years.

Plastic Wire, Rope & Knitting Seeing Rapid Growth in Output: among all the plastic packaging materials, the output of plastic film is the highest, while the output of plastic wire, rope and woven products among the subdivided products has seen the fastest growth. For example, the average output growth of plastic wire, rope and woven products in 2005-2010 reached 24.8%, compared with 13.1% and 13.5% for plastic film and plastic packaging container respectively.


The report highlights:
Current development, market size, competition pattern, supply and demand of global and China plastic packaging industry;

Import & export, industry barrier, outlook and development trend of China plastic packaging industry;

China plastic packaging upstream and downstream; focus on the status quo and demand of the three downstream sectors including food & drinks plastic packaging, pharmaceutical plastic packaging and cosmetic plastic packaging;

Operation, project planning, prospect concerning five global plastic packaging giants and 14 Chinese plastic packaging giants;


It is noteworthy that plastic packaging downstream consumer goods enterprises are very optimistic about the long-and medium-term development of China’s consumer goods market and have increased their investment in China. For instance, Unilever lavished over RMB12 billion to set up a base in Hefei; PepsiCo is set to invest additional USD2.5 billion in China and to set up 10-12 new plants. Overall, The continuous expansion of downstream consumer goods enterprises is bound to further fuel the demand for plastic packaging.

Contact us:
Reportstack http://www.reportstack.com/contact
twitter: http://twitter.com/reportstack
facebook: http://www.facebook.com/pages/Reportstack/182382778485635
linkedin: http://www.linkedin.com/company/reportstack